|
CRIPT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.978690E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.815500E-03 |
| Normal-vs-Stage2 |
3.329600E-01 |
| Normal-vs-Stage3 |
3.847100E-04 |
| Normal-vs-Stage4 |
1.26649999998563E-06 |
| Stage1-vs-Stage2 |
6.985400E-01 |
| Stage1-vs-Stage3 |
1.408990E-01 |
| Stage1-vs-Stage4 |
6.482200E-03 |
| Stage2-vs-Stage3 |
3.032400E-01 |
| Stage2-vs-Stage4 |
1.238240E-01 |
| Stage3-vs-Stage4 |
3.580800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.423140E-03 |
| Normal-vs-AfricanAmerican |
7.90520005011786E-09 |
| Normal-vs-Asian |
2.143800E-03 |
| Caucasian-vs-AfricanAmerican |
3.78050000000574E-05 |
| Caucasian-vs-Asian |
1.519010E-01 |
| AfricanAmerican-vs-Asian |
6.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.421500E-04 |
| Normal-vs-Female |
3.162500E-04 |
| Male-vs-Female |
5.689400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.379900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.103200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.982100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.668100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.245800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.393590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.806800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.750200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.066800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.155600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.324400E-01 |
| Normal-vs-Grade 2 |
6.523800E-02 |
| Normal-vs-Grade 3 |
4.10149999999776E-05 |
| Normal-vs-Grade 4 |
7.71329999982306E-07 |
| Grade 1-vs-Grade 2 |
9.422200E-01 |
| Grade 1-vs-Grade 3 |
2.626800E-01 |
| Grade 1-vs-Grade 4 |
5.935800E-02 |
| Grade 2-vs-Grade 3 |
1.643590E-02 |
| Grade 2-vs-Grade 4 |
5.556700E-04 |
| Grade 3-vs-Grade 4 |
6.011900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.804000E-01 |
| Normal-vs-ccB subtype |
1.50810000043577E-07 |
| ccA subtype-vs-ccB subtype |
4.29019999526048E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.545950E-02 |
| Normal-vs-N1 |
1.24779999999269E-07 |
| N0-vs-N1 |
8.38830000000623E-05 |
|
|
